Online Only Articles

Genetic heterogeneity highlighted by differential FDG-PET response in diffuse large B-cell lymphoma

Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK
Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK
Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK;Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK
Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK
Institute of Pathology, Cantonal Hospital St Gallen, St Gallen, Switzerland
Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK
Department of Nuclear Medicine, Cantonal Hospital St Gallen, St Gallen, Switzerland
King’s College London and Guy’s and St Thomas’ PET Centre, School of Biomedical Engineering and Imaging Sciences, King’s College London, King’s Health Partners, London, UK
Evolution and Cancer Laboratory, Barts Cancer Institute, Queen Mary University of London, London, UK
Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada
Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, AZ, USA
Cancer Research UK Centre, University of Southampton, Southampton, UK
Cancer Research UK Centre, University of Southampton, Southampton, UK
Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK
Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK
Clinic for Medical Oncology and Haematology, Cantonal Hospital St Gallen, St Gallen, Switzerland
Vol. 105 No. 6 (2020): June, 2020 https://doi.org/10.3324/haematol.2019.242206